Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$535M |
| 2 |
Meta Platforms (Facebook)
META
|
+$388M |
| 3 |
SLB Ltd
SLB
|
+$348M |
| 4 |
Visa
V
|
+$230M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$350M |
| 2 |
Chevron
CVX
|
+$349M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$337M |
| 4 |
Dell
DELL
|
+$332M |
| 5 |
SODA
SodaStream International Ltd
SODA
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.48% |
| 2 | Technology | 13.21% |
| 3 | Financials | 10.74% |
| 4 | Real Estate | 9.97% |
| 5 | Utilities | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Key Tronic
KTCC
$42.8M
| $105K | ﹤0.01% |
18,500
-18,300
| -50% | -$126K |
|
3227
CervoMed
CRVO
$23M
| $103K | ﹤0.01% |
691
+405
| +142% | +$138K |
|
3228
Riley Exploration Permian
REPX
$728M
| $103K | ﹤0.01% |
9,041
+131
| +1% | +$1.65K |
|
|
BVSN
3229
DELISTED
Broadvision Inc Com
BVSN
| $103K | ﹤0.01% |
90,500
+400
| +0.4% | +$675 |
|
|
CCRN
3230
DELISTED
Cross Country Healthcare
CCRN
| $101K | ﹤0.01% |
+13,800
| New | +$116K |
|
3231
Enlivex Ltd
ENLV
$37.9M
| $101K | ﹤0.01% |
1,084
+112
| +12% | +$17.2K |
|
3232
Aldeyra Therapeutics
ALDX
$97.1M
| $100K | ﹤0.01% |
12,000
+700
| +6% | +$7.17K |
|
3233
Traws Pharma
TRAW
$7.34M
| $99K | ﹤0.01% |
126
-23
| -15% | -$39.2K |
|
|
TI
3234
DELISTED
Telecom Italia
TI
| $99K | ﹤0.01% |
17,900
-43,372
| -71% | -$260K |
|
3235
Daxor
DXR
$61.5M
| $98K | ﹤0.01% |
12,000
-21,100
| -64% | -$137K |
|
|
IRD
3236
Opus Genetics
IRD
$287M
| $98K | ﹤0.01% |
+2,190
| New | +$128K |
|
|
CSCI
3237
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $97K | ﹤0.01% |
331
| – | – |
|
|
BDR
3238
DELISTED
Blonder Tongue Laboratories Inc
BDR
| $96K | ﹤0.01% |
86,857
-9,701
| -10% | -$10.6K |
|
3239
Dare Bioscience
DARE
$17.4M
| $95K | ﹤0.01% |
11,129
+1,617
| +17% | +$17K |
|
|
VERO
3240
DELISTED
Venus Concept
VERO
| $92K | ﹤0.01% |
+85
| New | +$327K |
|
3241
Newegg Commerce
NEGG
$273M
| $91K | ﹤0.01% |
500
-1
| -0.2% | -$263 |
|
3242
Xtant Medical Holdings
XTNT
$59.8M
| $90K | ﹤0.01% |
56,048
+5,700
| +11% | +$18.4K |
|
|
TISA
3243
DELISTED
TOP Image Systems Ltd
TISA
| $90K | ﹤0.01% |
180,200
+8,300
| +5% | +$6.23K |
|
3244
Armata Pharmaceuticals
ARMP
$168M
| $89K | ﹤0.01% |
30,890
+15,614
| +102% | +$76.1K |
|
3245
Eterna Therapeutics
ERNA
$3.98M
| $89K | ﹤0.01% |
3
| – | – |
|
3246
Koss Corp
KOSS
$34.4M
| $89K | ﹤0.01% |
46,696
-17,400
| -27% | -$40.1K |
|
|
AACG
3247
ATA Creativity
AACG
$38.9M
| $88K | ﹤0.01% |
95,500
-227,499
| -70% | -$245K |
|
3248
Cellectar Biosciences
CLRB
$19.8M
| $88K | ﹤0.01% |
190
-5
| -3% | -$3.56K |
|
3249
Veru
VERU
$35.5M
| $87K | ﹤0.01% |
6,230
-1,380
| -18% | -$19K |
|
|
SMRT
3250
DELISTED
Stein Mart Inc
SMRT
| $84K | ﹤0.01% |
78,858
-180,623
| -70% | -$310K |
|
Similar funds
Renaissance Technologies's Q4 2018 Portfolio in Review
As of Q4 2018, Renaissance Technologies held 3,847 positions worth $91.3B, down 6.1% from $97.3B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies deployed $8.84B of net new capital in Q4 2018, opening 522 new positions and adding to 1,588 existing holdings. Its largest new stake was Apple: 11,041,936 shares worth $435M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Dell, an estimated $332M trimmed.
- Renaissance Technologies's largest Q4 2018 buy was Apple: 11,041,936 shares worth $435M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2018, an estimated $388M increase.
- Renaissance Technologies's biggest Q4 2018 reduction was Dell, cutting an estimated $332M.
- Renaissance Technologies fully exited Danaher in Q4 2018, selling an estimated $350M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $91.3B portfolio in Q4 2018.
- Renaissance Technologies opened 522 new positions and closed 504 in Q4 2018.
- Renaissance Technologies's portfolio value fell 6.1% quarter-over-quarter to $91.3B.
Based on Renaissance Technologies's 13F filing for Q4 2018, filed 13 Feb 2019.